S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

IO Biotech (IOBT) SEC Filings & 10K Form

$1.76
+0.16 (+10.00%)
(As of 03/1/2024 ET)

Recent IO Biotech SEC Filings

DateFilerForm TypeView
02/13/2024
8:31 PM
IO Biotech (Issuer)
Novo Holdings A/S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:34 PM
IO Biotech (Subject)
Novo Holdings A/S (Filed by)
Form SC 13D/A
02/13/2024
6:38 PM
BANK OF AMERICA CORP /DE/ (Filed by)
IO Biotech (Subject)
Form SC 13G/A
02/09/2024
8:31 PM
IO Biotech (Subject)
Novo Holdings A/S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:11 AM
IO Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
4:14 PM
IO Biotech (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SC 13G
11/24/2023
4:37 PM
Burkavage Brian (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:47 PM
Collins Helen Louise (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:41 PM
Collins Helen Louise (Reporting)
IO Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2023
7:10 AM
IO Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2023
3:06 PM
IO Biotech (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
09/10/2023
11:15 PM
IO Biotech (Filer)
Form EFFECT
09/07/2023
9:36 AM
IO Biotech (Subject)
Kurma Partners (Filed by)
Form SC 13G
08/30/2023
3:16 PM
IO Biotech (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/21/2023
2:40 PM
IO Biotech (Issuer)
Kurma Partners (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2023
3:15 PM
IO Biotech (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
08/15/2023
5:02 PM
Hunter Heidi (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:57 PM
Hunter Heidi (Reporting)
IO Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2023
2:15 PM
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
IO Biotech (Subject)
Form SC 13G/A
08/14/2023
2:45 PM
IO Biotech (Subject)
Lundbeckfond Invest A/S (Filed by)
Form SC 13D/A
08/14/2023
2:45 PM
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
IO Biotech (Subject)
Form SC 13G/A
08/11/2023
8:22 PM
IO Biotech (Issuer)
Lundbeckfond Invest A/S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
8:24 PM
Elling Christian E (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
7:41 AM
IO Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2023
7:31 AM
IO Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
8:03 AM
IO Biotech (Issuer)
Vivo Capital Fund IX, L.P. (Reporting)
Vivo Capital IX, LLC (Reporting)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:43 PM
IO Biotech (Issuer)
Zocca Mai-Britt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:38 PM
IO Biotech (Issuer)
Smith Devin Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:41 PM
IO Biotech (Issuer)
Sullivan Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
7:31 AM
IO Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2023
3:10 PM
Ahmad Qasim Iftikhar (Reporting)
IO Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/19/2023
3:20 PM
Ahmad Qasim Iftikhar (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:05 PM
IO Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
7:06 AM
IO Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
6:54 PM
Elling Christian E (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
6:54 PM
Glaub Kathleen Sereda (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
6:54 PM
Hirth Peter (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
6:54 PM
IO Biotech (Issuer)
Nielsen Jack (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
6:54 PM
IO Biotech (Issuer)
Smith David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2023
3:39 PM
IO Biotech (Filer)
Form PRE 14A
03/22/2023
3:40 PM
Al-Hajj Muhammad (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2023
3:26 PM
IO Biotech (Issuer)
Sullivan Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2023
3:21 PM
Burkavage Brian (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2023
3:13 PM
Ehrnrooth Eva (Reporting)
IO Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2023
4:35 PM
IO Biotech (Issuer)
Sullivan Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2023
5:09 AM
IO Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2023
4:29 PM
IO Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IOBT) was last updated on 3/1/2024 by MarketBeat.com Staff